Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.

sclc2388_S39.txt

· cohortMD2

b3c419ae-94a5-5d95-adcc-60e91c2c7d1a

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
cohortMD2
subtype
cohortMD2

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

HTTPException: HTTP Error: Request returned HTTP 429 for HTTP HEAD to 'https://pub-e056b053afc04eec88337b62541f3025.r2.dev/oncoscape/lung-landscapes/6/gsva.parquet' LINE 1: SELECT pathway_library_id, pathway_name, gsva_score FROM read_parquet('https://pub-e056b053afc04eec88337b62541f3025... ^

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

2 twins match this tumor's tissue · 8 come from a different tissue of origin ← cross-tissue dominant

#SampleCancer typeSubtypecos similarity
1BS_6NTXGQAC
brain-umap@2
Ganglioglioma0.911
2ERR2598319
medullo-epn-umap@date-based
fetalfetal0.903
3MDT-AP-0410
medullo-epn-umap@date-based
MedMedulloblastoma0.900
4MDT-AP-1254
medullo-epn-umap@date-based
MedMedulloblastoma0.892
5ERR2598312
medullo-epn-umap@date-based
fetalfetal0.890
6SAMN03290935
melanoma-umap@29
0.889
7SRR2774182
melanoma-umap@29
0.885
8MDT-AP-0484
medullo-epn-umap@date-based
MedMedulloblastoma0.885
9SJEPD037_R.RNA-Seq
medullo-epn-umap@date-based
EPNPosterior Fossa EPN0.885
10SRR1431345
brain-umap@2
GTEX0.884

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 34 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
EPITHELIAL_MESENCHYMAL_TRANSITION0.470Inavolisib— uncovered
PANCREAS_BETA_CELLS0.430Cobimetinib— uncovered
COAGULATION0.420Binimetinib— uncovered
INFLAMMATORY_RESPONSE0.420Idelalisib— uncovered
REACTIVE_OXYGEN_SPECIES_PATHWAY0.420Inavolisib— uncovered
IL6_JAK_STAT3_SIGNALING0.370Inavolisib— uncovered
ALLOGRAFT_REJECTION0.360Idelalisib— uncovered
XENOBIOTIC_METABOLISM0.360Inavolisib— uncovered
TNFA_SIGNALING_VIA_NFKB0.340Inavolisib— uncovered
COMPLEMENT0.330Inavolisib— uncovered
KRAS_SIGNALING_UP0.330Inavolisib— uncovered
ANGIOGENESIS0.320Remibrutinib— uncovered
MYOGENESIS0.290Inavolisib— uncovered
IL2_STAT5_SIGNALING0.270Idelalisib— uncovered
INTERFERON_GAMMA_RESPONSE0.270Idelalisib— uncovered
CHOLESTEROL_HOMEOSTASIS0.230Remibrutinib— uncovered
FATTY_ACID_METABOLISM0.230Inavolisib— uncovered
HYPOXIA0.230Idelalisib— uncovered
APICAL_JUNCTION0.210Inavolisib— uncovered
ADIPOGENESIS0.200Inavolisib— uncovered